USD 1.66
(-5.68%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 7.36 Million | 8.47 Million | - | - |
Cost of Revenue | 1.75 Million | 5.94 Million | - | - |
Gross Profit | 5.61 Million | 2.52 Million | - | - |
Operating Expenses | 58.2 Million | 2.95 Million | 1.49 Million | 252.78 Thousand |
Selling, General and Administrative Expenses | 11.87 Million | 2.95 Million | 1.49 Million | 252.78 Thousand |
Research and Development Expenses | 6.97 Million | 9.32 Million | - | - |
Other Expenses | 39.35 Million | 9.66 Million | - | - |
Cost and Expenses | 59.95 Million | 2.95 Million | 1.49 Million | 252.78 Thousand |
Operating Income | -52.58 Million | -2.95 Million | -1.49 Million | -252.78 Thousand |
Interest Expense | - | - | - | - |
Income Tax Expense | -3.57 Million | 49.17 Thousand | -68.36 Thousand | -606.67 Thousand |
Earnings before Tax | -57.19 Million | 17.68 Million | 9.2 Million | -4.08 Million |
Net Income | -53.61 Million | 17.63 Million | 9.2 Million | -4.08 Million |
Earnings Per Share Basic | -4.32 | 0.91 | 0.27 | -0.12 |
Earnings Per Share Diluted | -4.70 | 0.91 | 0.27 | -0.12 |
Weighted Average Shares Outstanding | 12.41 Million | 19.44 Million | 34.5 Million | 34.5 Million |
Weighted Average Shares Outstanding (Diluted) | 11.4 Million | 19.44 Million | 34.5 Million | 34.5 Million |
Gross Margin | 0.76 | 0.30 | - | - |
EBIT Margin | -7.27 | -1.59 | - | - |
Profit Margin | -7.28 | 2.08 | - | - |
EBITDA | -53.58 Million | -19.46 Million | - | - |
Earnings Before Tax Margin | -7.14 | -0.35 | - | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Revenue | 1.76 Million | 1.81 Million | 1.71 Million | 7.36 Million | 1.77 Million | 2.25 Million |
Cost of Revenue | 1.03 Million | 1.01 Million | 995 Thousand | 4.71 Million | 358 Thousand | 567 Thousand |
Gross Profit | 730 Thousand | 808 Thousand | 724 Thousand | 2.64 Million | 1.41 Million | 1.69 Million |
Operating Expenses | 4.38 Million | 4.39 Million | 4.12 Million | 18.63 Million | 5.61 Million | 5.69 Million |
Selling, General and Administrative Expenses | 2.64 Million | 2.79 Million | 2.26 Million | - | 3.34 Million | 3 Million |
Research and Development Expenses | 1.73 Million | 1.59 Million | 1.86 Million | - | 1.56 Million | 1.87 Million |
Other Expenses | -30 Thousand | -56 Thousand | 4.12 Million | 6.76 Million | -24 Thousand | 7000.00 |
Cost and Expenses | 5.41 Million | 5.4 Million | 5.12 Million | 23.35 Million | 5.96 Million | 6.26 Million |
Operating Income | -3.65 Million | -3.58 Million | -3.4 Million | -15.99 Million | -4.22 Million | -4.17 Million |
Interest Expense | -684 Thousand | 262 Thousand | - | - | - | - |
Income Tax Expense | -159 Thousand | -207 Thousand | -614 Thousand | -3.57 Million | -417 Thousand | -2.54 Million |
Earnings before Tax | -5.41 Million | -5.37 Million | -39.32 Million | -57.19 Million | 1.02 Million | -14.51 Million |
Net Income | -5.25 Million | -5.17 Million | -38.7 Million | -53.61 Million | 1.44 Million | -11.97 Million |
Earnings Per Share Basic | -0.34 | -0.34 | -2.54 | - | 0.13 | -0.85 |
Earnings Per Share Diluted | -0.34 | -0.34 | -2.54 | - | 0.13 | -0.85 |
Weighted Average Shares Outstanding | 15.25 Million | 15.25 Million | 15.25 Million | 15.25 Million | 10.81 Million | 14.06 Million |
Weighted Average Shares Outstanding (Diluted) | 15.25 Million | 15.25 Million | 15.25 Million | 15.25 Million | 10.81 Million | 14.06 Million |
Gross Margin | 0.41 | 0.44 | 0.42 | 0.36 | 0.80 | 0.75 |
EBIT Margin | -1.61 | -1.53 | -1.53 | - | -4.91 | 3.30 |
Profit Margin | -2.98 | -2.84 | -22.52 | -7.28 | 0.81 | -5.30 |
EBITDA | -2.84 Million | -2.77 Million | -2.63 Million | - | -8.69 Million | 7.45 Million |
Earnings Before Tax Margin | -2.07 | -1.97 | -1.98 | -2.17 | -2.39 | -1.85 |
NXS
SMP
LTRN
3521
MLHK
FALABELLA